Hematopoiesis is regulated by two sets of signals, those generated by cytokines and those generated when precursor cells interact with bone marrow (BM) stroma. The intimate contact between precursors and stroma appears t o be mediated by multiple, different receptor-ligand binding events. To identify receptor-ligand pairs mediating the adhesion of hematopoietic precursor cells t o stroma, an in vitro model of hematopoiesis was used. This involved coculturing the BM-derived, interleukin-3 (IL-3)-dependent, multipotential cells, FCDP-mix A4 (A4) with a stromal equivalent embryonic mesenchymal cell line, Swiss 3T3 (3T3). In coculture, A4 cells survive, proliferate, and differentiate in the absence of exogenous 11-3, providing they are attached to the 3T3 cell surface. By using detergent lysates of surface-biotinylated A4 cells, A4 cell molecules that bind to the stroma could be detected by either fluorescein isothiocyanate (FITCI-strep-ITHIN THE bone marrow (BM), the development of different hematopoietic lineages appears to be regionally localized with particular types of stromal cell niches being required for the development of different lineages.',2 At least five stromal cell subsets have been identified in BM cultures in vitro. These include endothelial cells, macrophages, "blanket cells," adipocytes, and pre-adipocytic fibroblast~.~ It is well established that erythroid cells will associate with and develop on stromal macrophages4.' and that multipotential, myeloid, and B-lymphoid cells require the presence of fibroblastoid-like cells!. ' Molecular explanations for this organization must involve both the production of different cytokines and the expression of an array of cellsurface molecules that are characteristic of each stromal cell subset.' The intimate contact between hematopoietic precursors and stromal cells necessary for lineage commitment is undoubtedly mediated not only by cell-cell interactions involving adhesion molecules on precursors and stromal cells but also by precursor cells interacting with the extracellular matrix secreted by the stroma.
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A number of molecules within the integrin and Ig superfamilies of cell-adhesion molecules have been found to mediate hematopoietic precursor cell interactions with BM stromal cells. In the human these include VLA-4NCAM-l," VLA-S/fibronectin,l' PECAM-1 (CD3 l)/PECAM-l, and PECAM-lheparan sulfate receptor ligand pairs,I2 with VCAM-1, PECAM-1, heparan sulfate, and fibronectin being present on or associated with the stromal layer. In the mouse, VLA-4NCAM-1 and VLA-4lfibronectin interactions have been de~cribed.'~.'~ Antibodies to a molecule of a different structure, CD44, also inhibited hematopoiesis in long-term BM cultures." Hyaluronate associated with the stromal layer is the ligand for CD44.I6 In addition, a recent report implicated heparan sulfate associated with BM stromal cells as a molecule mediating the adhesion of primitive hematopoietic cells to stroma; its ligand was not identified.17 Research over the last decade has indicated that GAGs, and in particular heparan sulfates, are likely to play an important role in cellcell interactions and cell differentiation. Indeed, heparan sulfate is likely to play a key role in hematopoiesis because in addition to its role in the adhesion of progenitor cells to interleukin-3 (IL-3) and granulocyte-macrophage colonystimulating factor (GM-CSF) to progenitor cells." The plethora of molecules described as mediators of progenitor cell adhesion with BM stroma probably reflects differences in, firstly, the differentiation stages of the hematopoietic cells; secondly, the stromal elements to which cells adhere; and finally the manner in which cell adhesion is regulated and stabilized.
Cell-cell adhesion is not mediated by a single receptor/ ligand pair but rather multiple interactions consisting of several different receptorfiigand pairs are required for stable adhesion and for the specificity of the adhesive interactions observed in vivo. The notion of an adhesion cascade has been proposed" where the engagement of one receptor with its ligand may trigger enhanced adhesion through another receptorfligand pair. Current assays, in which cell-adhesion molecules are identified through the use of monoclonal antibodies (MoAbs) that block adhesion, do not readily permit the identification of more than one receptorfligand pair. We report here the development of a method that allows multiple molecular interactions to be identified and is not dependent on blocking MoAbs. The complexity of the BM microenvironment and of the cell-cell interactions occumng within it stroma,12.17.18 BM heparan sulfate also binds and presents 7 40 COOMBE, WATT, AND PARISH are such that a simplified system must be used for this type of biochemical analysis. The method was developed using the model system for stromal cell-mediated hematopoiesis described by Roberts et aL6 A multipotential hematopoietic cell line, FDCP-mix A4 (A4), established from mouse BM cultures, is cocultured with Swiss 3T3 cells, a murine embryonic mesenchymal cell line, as the stromal layer. A4 cells are dependent on IL-3 for their growth in suspension CUItures, but survive, proliferate, and differentiate, predominately into neutrophils and macrophages, in the absence of added IL-3 when grown as a coculture.' Essential to proliferation and differentiation of the hematopoietic cells in the cocultures is their intimate association with the 3T3 cell layer. The coculture is a simplified system in comparison with whole marrow, but characteristics of BM cultures, in particular controlled progenitor cell proliferation and differentiation without exogenous cytokines, are retained. Thus, it is an ideal system with which to obtain clues as to the molecular interactions regulating hematopoiesis in the BM.
To dissect the molecular nature of A4 cell interactions with the 3T3 cells we developed a procedure based on the binding to one cell type of detergent lysates prepared from surface-biotinylated cells of another type, binding being detected by fluorescein isothiocyanate (F1TC)-streptavidin staining and quantified by flow cytometry. Using this procedure, we show that heparan sulfate mediates the adhesion of A4 cells to 3T3 cells and its ligands on the multipotential progenitors were identified as the p2 integrin, Mac-l, and CD45, a receptor-type tyrosine phosphatase. Detection of antigens on A4 cells. A4 cells were washed and resuspended to 4 X IO6 per mL in RPMI/BSA. Twenty microliters of cells was added to 20 pL MoAb diluted as appropriate in wells of a V-bottomed plate and the assay performed as for detection of lysate proteins bound to 3T3 cells. The MoAbs were used at saturating concentrations.
MATERIALS AND METHODS

Biochemicals
Adsorption of A4 cell lysate by afJigel heparin. One hundred twenty microliters of packed affigel heparin beads (Bio-Rad Laboratories, Richmond, CA) or uncoupled beads (control) were washed and preadsorbed with 300 pL RPMVBSA for 30 minutes at 4°C. The beads were sedimented and 60 pL of beads mixed with 80 pL of A4 cell lysate diluted with 40 pL of RPMVBSA and incubated for 3 hours at 4°C with rotation. The supernatants were then added to a further 60 pL packed beads and incubated Overnight at 4°C with rotation. Supernatants were diluted with RPMVBSA to give a 115 dilution of the original lysate, and binding activity on 3T3 cells was analyzed by flow cytometry.
Immunodepletion of lysate. Protein G Sepharose 4B Fast Flow beads (Pharmacia-LKB) preabsorbed with RPMI/BSA were divided into 200 pL aliquots of packed beads. One aliquot was mixed with 150 pL of MU9 and 150 pL of YBM42 (anti-CD45 beads), another with 150 pL of W 6 9 and 150 pL Ml/7O (anti-Mac-l beads), and the third was incubated with 300 pL of 50 pg/mL of CAMPATH diluted in RPMI containing 10% FCS (control beads). MoAbs except CAMPATH were culture supernatants concentrated 10-fold in a minicon concentrator (Amicon Ltd. Stonehouse, Gloucestershire, UK). The beads were incubated for 3 hours at 4°C with rotation, then washed with 3 X 600 pL of RPMVBSA. One hundred microliters of each lot of beads was mixed with 60 pL of A4 cell lysate diluted with 40 pL of RPMVBSA and incubated at 4°C for 4 hours. The beads were sedimented and supernatants added to a fresh 100 pL of MoAb-coated packed beads and incubated overnight. Supernatants were diluted with RPMVBSA to give a 115 dilution of the original lysate and binding activity on The column was washed with 0.15 m o m NaCI, 20 mmoyL Na acetate pH 4.0, and eluted with a salt gradient: 75 mL 0.15 moVL NaCl and 75 mL 1.5 moVL NaCl in acetate buffer. The column was run at 8 mLm and 2-mL fractions collected. One peak of labeled material was obtained. Peak fractions were pooled, dialyzed versus 2 X 3 L 20 mmol/L Tris-HC1, 0.15 molL NaCI, and concentrated on a 2-mL DEAE Sephacel column by eluting with 4 mL 1 molL NaCl in acetate buffer. After dialysis against 20 mmom Tris-HCI pH 8.0, 0.5 m o m NaCI, the 4-mL sample was applied to a 2.6 X 63 cm Sepharose CL 6B (Pharmacia LKB) column equilibrated in this buffer. The column was run at 8 mL/h and 2-mL fractions collected and assessed for radioactivity. Blue dextran and phenol red identified V, , and V,, respectively.
Enzymatic and nitrous acid treatment of GAGs. For glycanase digestion," 3T3 cells were washed and resuspended at 5 X lo6 cells/ mL in RPMI supplemented with 0.5% BSA, 1 mmol/L HEPES, 1 mmoVL CaCI2, and 1 mmoVL MgCI2 (digestion buffer). To 250 pL of cells was added 0.5 IU of heparinase III or chondroitinase ABC, or no enzyme (controls). Cells were incubated at 37°C for 60 minutes with gentle shaking, then washed with 2 X 5 mL RPMYBSA and resuspended at 4 X lo6 cells/mL in ice-cold RPMYBSA for reaction with lysates and subsequent flow cytometry. Activity of the enzymes was confirmed by reacting 50 pg of heparan sulfate or chondroitin sulfate (mixed isomers) in 50 pL of digestion buffer with 0.25 IU of heparinase III or chondroitinase ABC, respectively, for 60 minutes at 37°C. The samples were boiled and subjected to 10% to 20% gradient sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The gels were fixed with 50% methanOv7% acetic acid, washed for 2 hours with 5% methanoV7% acetic acid to remove SDS, and then stained with toluidine blue." Controls were 50 pg of the undigested GAG.
GAGs purified from 3T3 cells were digested with 0.25 IU/mL heparinase I11 in 20 mmom Na acetate/lO mmoVL CaClz/lOO pg/ mL BSA, pH 7.0, and 0.25 IU/mL chondroitinase ABC in 50 mmoll L Tris-HCU5O mmoVL Na acetate/0.15 m o m NaCYl00 pg/mL BSA, pH 8.0 for 12 hours at 37°C. Samples were then dialyzed against distilled water, freeze dried, and electrophoresed on SDSpolyacrylamide 10% to 20% gradient gels and the GAGs visualized by fluorography. Nitrous acid deamination was performed by the low pH pr~cedure,'~ and the treated samples then dialyzed and electrophoresed as described. adhesion assay (Fig IA) . In contrast, A4 cells previously preincubated with 200 pg/mL of heparin and added in the presence of heparin, to 3T3 cells, bound extremely poorly, if at all (Fig IC) . whereas A4 cells similarly treated with 200 pg/mL of another GAG, chondroitin-&sulfate. adhered to the 3T3 cells in a manner indistinguishable from that of the control where no GAG was present (Fig IB) . Attempts to identify the GAG-binding molecules involved in this interaction by using MoAbs to adhesion molecules were unsuccessful because the MoAbs used failed to block binding.
RESULTS
Binding
To In subsequent experiments, binding of the biotinylated lysate to 3T3 cells was quantified by flow cytometry (Fig   2) . The fluorescence intensity of 3T3 cells reacted with a I / IO dilution of the biotinylated lysate and stained with FITCstreptavidin was at least ninefold that of 3T3 cells stained with FITC-streptavidin but not reacted with the lysate (negative control). and with some lysate preparations it was as much as 17-fold (Fig 2) . 3T3 cells incubated with lysis buffer alone gave a fluorescence intensity identical to the negative control (data not shown). All the 3T3 cells in the suspension bound the biotinylated cell-surface proteins in the lysate (Fig  2) and titration curves did not show saturable binding over the concentrations tested (Fig 2. inset) . When the A4 cell lysate was incubated with a rat fibroblast cell line. RF208, the biotinylated cell-surface proteins bound very poorly, giving a fluorescence intensity only marginally above that of the control even at the highest concentration of lysate (Fig 2. inset) . A4 cells do not adhere to RF208 cells. nor do these tibroblasts support the proliferation and differentiation of A4 cells (D.R.C., unpublished data, June 1989). The finding that biotinylated A4 cell-surface proteins did not bind RF208 cells is consistent with this coculture result. These data indicate that solubilized, A4 cell-surface proteins bind only certain cells and suggest that this assay could be used to identify the molecular interactions involved in the adhesion of A4 cells to 3T3 cells.
To determine whether the heparin-binding proteins were on the surface of the 3T3 cells or in the A4 cell lysate, biotinylated lysate was preabsorbed with heparin-coupled beads and tested for its ability to bind 3T3 cells. To control for nonspecific adsorption, biotinylated lysate was reacted with uncoupled beads and examined for its ability to bind 3T3 cells. The geometric mean intensities of fluorescence obtained with lysate reacted with the heparin-coupled beads compared to that obtained with lysate adsorbed with control beads indicated that 97% of the binding activity was removed by the heparin-coupled beads (Fig 3A) . Thus, molecules on the surface of the A4 cells bind heparin and at least some of these molecules also bind the 3T3 cells, probably via a heparinlike GAG. When a dot blot of serially diluted samples from these two lysate preparations was stained for biotin it was apparent that lysate depleted of 97% of its binding activity by heparin-coupled beads had retained virtually equivalent amounts of biotinylated protein as lysate preabsorbed by uncoupled beads (Fig 3B) . Therefore, the heparin-binding 
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proteins comprise only a small fraction of the total biotinylated proteins in the lysate, and from Fig 3A it is clear that most of the lysate molecules which bind 3T3 cells also bind heparin.
Specijicify of binding of A4 cell lysate to 3T3 cells. This question was examined by testing different GAGS for their ability to inhibit lysate binding. It is clear from Fig 4 that heparin and heparan sulfate were the most effective inhibitors and dermatan sulfate partially inhibited lysate binding, whereas hyaluronic acid, chondroitin-4-sulfate, and chondroitin-6-sulfate were without effect. The quantitative flow cytometric assay verified the initial observations obtained using fluorescent microscopy (data not shown). Titration curves of the three inhibitory GAGS showed that heparan sulfate and heparin were equally effective at high concentrations, but at concentrations less than 10 pg/mL heparin was the more effective inhibitor, exhibiting significant activity at sub-microgram concentrations (Fig 5A) . Dermatan sulfate was a poor inhibitor, with a concentration of 35 p g / d being required to give 50% inhibition. These results suggest that negative charge alone is not sufficient for inhibition of lysate binding, but both sulfation and the monosaccharide constituents of the GAG chain are critical parameters.
To examine whether a particular GAG motif is required for inhibitory activity a series of modified heparins were Log Fluorescence Intensity tested. Figure 5B shows that native heparin was the most effective inhibitor. Totally desulfated heparin and desulfated heparin with an acetoacetyl group substituted at the N-position of the glucosamine residues were both poor inhibitors, being partially effective only at 100 to 200 pg/mL. Heparin with the sulfate removed at the N-position was as active as native heparin at 100 to 200 pg/mL but its activity titrated out much sooner (50% inhibition at 7 pg/mL for N-desulfated heparin and 0.3 pg/mL for native heparin). Interestingly, acetylation of this N-position restored inhibitory capacity such that at 4 pg/mL and above the activity of this molecule mirrored that of native heparin and its activity was only slightly less than the unmodified molecule at lower concentrations. Reduction of the carboxyl group caused the heparin preparation to lose a little of its activity, 2 to 3 pg/ mL being sufficient to give 50% inhibition. Collectively these data point to a particular GAG structure, rather than just any anionic polysaccharide, being required for inhibition.
IdentiJcation of A4 cell-surface antigens that bind 3T3 cells. A4 cells were screened by flow cytometry for expression of Ags reported as being involved in cell adhesion. It can be seen from Fig 6 that in the dot blot and, although fourfold higher than that of the isotype-matched control MoAb, it was possible that some antigenicity of this protein was lost.
To identify which proteins in the A4 cell lysate bound the 3T3 cells, a nonbiotinylated lysate was incubated with 3T3 cells and these cells were examined for their ability to bind MoAbs used in Fig 6. 3T3 cells not incubated with the lysate were tested for background expression of the same Ags. Flow cytometric analysis showed some interesting findings. Only KM201 bound untreated 3T3 cells (Fig 7i) , indicating that CD44 is the only Ag examined expressed by both cell types. There was a marginal shift in the fluorescence intensity curve obtained with this MoAb after pretreatment of the 3T3 cells with lysate. The anti-L-selectin MoAb, MEL-14, and the MoAb recognizing LPAM-I , R 1-2, also showed little change in their binding patterns after the 3T3 cells were incubated with lysate (Fig 7, g and h) . In contrast, a dramatic increase in the binding of MoAbs recognizing CD45 (M 119 and YBM42) and Mac-l (YW69 and M1/70) was observed (Fig 7, a, b, d , and e), indicating that these A4 cell-surface Ags bind to the 3T3 cells. No such change was seen with the other p2 integrin MoAb tested, M17/42 (Fig 7f) . It also appears that the B-lymphocyte isofom of CD45 binds very poorly to the 3T3 cells (Fig 7c) . However, because the expression of this Ag by the A4 cells is low it may be that the assay lacks the sensitivity to detect binding. A similar argument could be used to explain the very slight increase in the fluorescence intensity observed with the anti-CD44 MoAb. These two Ags were not examined further.
Because cholate is a relatively weak detergent, solubilization of the A4 cell membrane may have been incomplete, giving rise to aggregates containing both CD45 and Mac-l. To ascertain that Mac-I and CD45 each independently bound the 3T3 cells the following experiment was performed. The lysate was preabsorbed with protein G beads previously coated with either the two CD45 MoAbs or the two Mac-l MoAbs. A lysate preparation, similarly preabsorbed with protein G beads coated with an irrelevant MoAb, was the control. After preabsorption the lysates were incubated with 3T3 cells and these cells were examined for their capacity to bind a CD45 MoAb and a Mac-l MoAb. Flow cytometry analysis showed that the removal of one Ag did not affect the capacity of the other Ag to bind the 3T3 cells (Fig 8) .
GAGs inhibit the binding of CD45 and Mac-] to 3T3 cells. If CD45 or Mac-l are molecules involved in the adhesion of A4 cells to the 3T3 cell layer, then at least one of these Ags should bind GAGs in a pattern similar to that observed with whole lysate (Fig 4) . Accordingly, the A4 cell lysate was preincubated with GAGs before being added to the 3T3 cells. These cells were stained for CD45 or Mac-l, using the MoAbs M1/9 and YW69, respectively, and analyzed by flow cytometry. The results (Fig 9) clearly indicate that both Ags were blocked from binding the 3T3 cells by certain GAGs, although the pattern of GAG inhibition was distinctive for each Ag. Chondroitin sulfate (both 4 and 6 sulfate) did not inhibit the binding of either Ag. Hyaluronic acid had no effect on the binding of the CD45 but exhibited weak inhibition of Mac-l, the MoAb to this Ag giving a level of binding around 80% of the positive control. Dematan sulfate markedly inhibited the binding of Mac-l; the binding of
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ii Log Fluorescence Intensity iii trast, RA3, an MoAb to the B-lymphocyte form of CD45 (B220), gave only a threefold increase in fluorescence intensity over that of the isotype-matched control antibody. An increase of around eightfold was observed with MoAbs to Mac-l, CD1 la (LFA-l), L-selectin, and LPAM-I whereas the MoAb recognizing CD44 gave an increase in fluorescence intensity of approximately threefold.
It was possible that cholate may alter the antigenicity of the A4 proteins. Hence, the effect of cholate on the antigenicity of the A4 proteins was examined by performing dot blots of the A4 cell lysates, the antibody bound being detected using the horseradish peroxidase detection system and quantified by densitometry. The MoAb giving the strongest signal was YW69. The other MoAbs with the exception of RI-2 gave signals mirroring that obtained with MoAb binding to the intact A4 cells (Fig 6) . RI-2 produced the weakest signal For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From 
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Relative Fluorescence Intensity of GAG inhibition is distinctive for both Ags supports the conclusion from Fig 8 that Mac-l and CD45 each bind 3T3 cells independently. In addition, heparin-coupled beads completely depleted CD45 and Mac-1 from A4 cell lysates. When lysates preabsorbed with heparin-coupled beads were incubated with 3T3 cells, MoAbs recognizing CD45 and Mac-1 no longer stained the cells, whereas 3T3 cells incubated with unabsorbed lysate stained strongly with both CD45 and Mac-l MoAbs (data not shown).
Heparan sulfate is required for CD45 and Mac-I to bind to 3T3 cells. The data suggest that A4 cells, and solubilized A4 cell-surface proteins, bind 3T3 cells via a GAG synthesized by these cells, probably a heparan sulfate. Purification of the GAGS in the 3T3 cell layer metabolically labeled with [%]sulfate indicated that both heparan sulfate and chondroitin sulfate were synthesized by these cells. The labeled GAGS eluted as a single peak from DEAE-Sephacel at an NaCl concentration of 0.65 mol&, but two peaks were resolved upon rechromatography of the GAG-containing fractions on Sepharose 6B (data not shown). GAGS with an average molecular weight of 85 kD were found to be heparan sulfate because of a sensitivity to heparanase I11 digestion and nitrous acid cleavage while resistant to chondroitinase ABC. In contrast, GAGS in the second peak, with an average molecular weight of 45 k D , were resistant to nitrous acid and heparanase I11 cleavage but sensitive to chondroitinase ABC and therefore were chondroitin sulfate. The chondroitin sulfate was deposited in the extracellular matrix because the '%-labeled GAGS in the material remaining on the culture flask after the cells were removed with 10 mmoW EDTA was entirely chondroitin sulfate (data not shown). Because there was no evidence of heparan sulfate in the matrix fraction this suggests that heparan sulfate is located on the 3T3 cell surface.
To confirm that heparan sulfate is the ligand for the A4 cell-surface proteins, heparan sulfate on the 3T3 cells was destroyed by treatment with heparinase I11 before these cells were incubated with biotinylated A4 cell lysates and staining with FITC-streptavidin. It is clear from Fig 10a that very little lysate bound to cells treated with heparinase 111. In contrast, cells treated with chondroitinase ABC bound lysate in a fashion similar to the control cells not previously enzyme digested (Fig 10d) . Similarly, 3T3 cells treated with heparinase I11 bound neither CD45 nor Mac-l MoAbs, whereas cells treated with chondroitinase ABC bound both MoAbs almost to the same extent as cells not digested with the enzymes (Fig 10, b, c , e, and f). As before (Fig 7) , the binding of MoAbs recognizing CD45 or Mac-l to 3T3 cells was entirely dependent on preincubation of these cells with the A4 cell lysate. Glycanase digestion of the 3T3 cell surface neither created novel epitopes recognized by the MoAbs, nor did it affect the epitope on CD44 to which the MoAb KM201 binds (data not shown).
DISCUSSION
Molecules involved in cell-cell interactions are often identified through the use of MoAbs that block adhesion. Although a powerful technique, MoAb blocking can be problematical. When adhesion is mediated via multiple, receptorligand pairs, the blocking of one type of receptor-ligand interaction may not reproducibly destabilize adhesion. Similarly, an MoAb may block cell adhesion by indirect means such as cell activation. We describe here a new method for identifying molecules involved in cell-cell interactions. This method is not dependent on blocking MoAbs and has the advantages of high reproducibility, sensitivity, rapid and accurate quantification, and permits identification of multiple receptor-ligand pairs. However, the molecular interactions identified may not necessarily be involved in cell adhesion. The procedure is based on cholate solubilization of cells and the binding of the solubilized molecules to a second intact cell. The extent of binding is detected by probing reacted cells with FITC-labeled antibodies and quantified by flow cytometry. Labeling the cell surface with biotin before detergent lysis and then staining lysate-reacted cells with FITC-
Log Fluorescence Intensity streptavidin allows visualization of the full complement of biotinylated surface proteins that bind. Cholate lysates have the advantage, because of the high critical micelle concentration of the detergent, that they can be used at low dilution without target cell lysis.
This method was used to identify molecules mediating the interaction of a murine multipotential hematopoietic cell line, A4, with the stromal equivalent, 3T3 cells. It was found that binding of biotinylated A4 cell proteins was readily detected on the surface of intact 3T3 cells. Binding was not indiscriminate, because these biotinylated proteins bound poorly to rat fibroblasts, cells to which intact A4 cells do not adhere. CD45 and Mac-l were identified as molecules in the A4 cell lysate that bound 3T3 cells, and it is likely that they also mediate the adhesion of A4 cells to 3T3 cells. The ligands on the 3T3 cells for CD45 and Mac-l appear to be different structural motifs within heparan sulfate.
Cell adhesion studies showed that heparin inhibited adhesion of intact A4 cells to 3T3 cells, whereas chondroitin sulfate was inactive. Heparin and heparan sulfate, but not For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From
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Log Fluorescence Intensity chondroitin sulfate, also inhibited the binding of biotinylated A4 cell-surface proteins to 3T3 cells. Titration experiments indicated that very low concentrations of heparin and heparan sulfate, around 0.5 pg/mL and 1.5 pg/mL, respectively (Fig 5A) , could inhibit by 50% the binding of the biotinylated proteins. The sensitivity of this method allowed identification of structural features within the GAG molecule necessary for inhibition. The presence of iduronic acid appeared critical because the iduronic acid containing GAGs, heparin, heparan sulfate, and dermatan sulfate all inhibited binding. Although dermatan sulfate was a weak inhibitor, chondroitin sulfate, a molecule with a similar overall charge but containing glucuronic acid, was inactive. Thus, negative charge alone is not sufficient; activity in this system also requires the appropriate monosaccharide constituents. Heparin and heparan sulfate share many structural features3' and the availability of chemically modified heparins permitted analysis of the structure necessary for activity. Carboxyl-reduced heparin was slightly impaired in its inhibitory activity compared with unmodified heparin, indicating that the carboxyl groups of uronic acid contribute only slightly to the motif recognized. Totally desulfated heparin was a very poor inhibitor whereas N-desulfated heparin showed reduced activity, but substitution of the exposed amino group with an acetyl group restored activity. Heparin and heparan sulfate are 0-sulfated at C-6 of GlcNSO,, at C-2 of iduronate, and occasionally at C-6 of GlcNAc. Collectively the data from the inhibition studies indicate that 0-sulfate rather than N-sulfate groups are essential for inhibitory activity and suggest that the presence of 0-sulfated iduronic acid is a critical feature of the motif recognized by A4 cell membrane proteins on 3T3 cells.
The data suggest that CD45 and Mac-l on A4 cells bind both 3T3 cells and GAGs. It is likely that other A4 cell surface proteins which don't bind GAGS do bind the 3T3 cells. However, because heparin inhibited, by approximately 95%, the quantity of biotinylated protein that bound the 3T3 cells, non-GAG-binding proteins comprise a minor proportion of the molecules that bind these cells. Differences exist in the GAG structures that are recognized by CD45 and Mac-1. CD45 binds structural motifs present only in heparin and heparan sulfate whereas Mac-l also binds motifs in dermatan sulfate. Like heparin and heparan sulfate, dermatan sulfate contains 2,O-sulfated iduronic acid residues. Thus, it appears that Mac-l is not as specific as CD45 in the structure it recognizes. Whether or not CD45 binds a GAG motif in a highly specific manner reminiscent of the antithrombin IIIheparin interaction, where a defined oligosaccharide with precise placing and orientation of the sulfate groups is required:' awaits investigation. Current data indicate that the disaccharide components in heparan sulfate are distributed nonrandomly along the polysaccharide chain. Clusters of highly sulfated domains rich in 0-sulfated iduronic acid are separated by nonsulfated regions predominately consisting of N-acetyl-glucosamine alternating with glucuronic The evidence suggests that these sulfation patterns are celltype Mac-l and CD45 could bind heparan sulfate from different cells with varying affinity depending on the arrangement of the sulfate-rich domains. The probable explanation for the poor binding of A4 cell-surface proteins to rat fibroblasts is that the sulfation pattern of heparan sulfates on these cells allowed mouse CD45 and Mac-l to bind only with very low affinity.
The 3T3 cells produce both chondroitin sulfate and heparan sulfate. The overall charge of these two GAGs is similar because a single peak of 35S-labeled material was obtained after chromatography on DEAE-Sephacel (data not shown). Unlike the chondroitin sulfate, heparan sulfate was not deposited in the extracellular matrix synthesized by these cells, a result also obtained with BM stromal cells.34 Despite adding calcium, A4 cells did not adhere to the matrix remaining on the culture flask after the 3T3 cells were released with EDTA (S.M.W. and D.R.C., unpublished data, May 1988), a finding consistent with chondroitin sulfate not being involved in adhesion. Our lysate binding studies also provide no evidence for the involvement of chondroitin-4-sulfate in adhesion, a GAG produced by the A4 cells. 35 Others have reported that chondroitin sulfate on related cells, FDCP-1, binds fibronectin, thereby mediating their adhesion to stroma.36 A4 cells, in contrast, do not bind fibronectin-coated dishes (S.M.W., unpublished data, May 1988). Our findings are consistent with those of Siczkowski et al.'7 They concluded that heparan sulfate is involved in adhesion of human progenitor cells to BM stroma, possibly in concert with other adhesion molecules.
CD45 and Mac-l may not bind GAGS directly but could be tightly associated with two unidentified proteins that bind GAGS with the specificity indicated. This is considered unlikely. Two groups have reported that CD45 binds a range of sulfated polysaccharides including heparin, fucoidan, and dextran s~l f a t e .~~.~~ Moreover, only certain isoforms of CD45 bind GAGs, the 180-kD molecule that lacks the three Nterminal exons being the prime GAG-binding i s o f~r m ,~~ a conclusion consistent with our data (Fig 7) . There is a precedent for integrins binding sulfated polysaccharides. Dextran sulfate was reported to bind LFA-1 (CD1 ldCD18) via an epitope probably on CD1 la.38 Additional ligands for Mac-l are not surprising because this integrin has promiscuous binding behavior, and its ligands include the complement component iC3b, ICAM-1, fibrinogen, lipopolysaccharide, and p -g l~c a n .~,~~ Furthermore, there are two regions in the (Y chain4' that have characteristics of GAG-binding sites ie, clustered basic amino acids in hydrophobic regions.43 One sequence is within a 220-amino acid domain that is homologous to a region in von Willebrand factor (vWF) present as three tandem repeats, Al, A2, and A3; cartilage matrix protein; and the complement factors B and
The A1 domain of vWF binds heparin" and heparin interferes with reactions in the alternative pathway of complement involving the third complement component (C3), factor B, and factor D. 45 This sequence is also within the ligand-binding region proposed for a generalized integrin."6
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org This study identified CD45 and Mac-l on the A4 cell surface as molecules that bind heparan sulfate on 3T3 cells. MoAbs to these proteins did not inhibit adhesion of A4 cells to the 3T3 cells possibly because the MoAbs tested do not recognize heparan sulfate-binding epitopes. For example, 5C6, an MoAb reported to inhibit macrophage and monocyte adhesion to endothelia mediated by Mac-1; ' did not significantly block A4 cell adhesion to the 3T3 cells. However, this MoAb did stain 3T3 cells previously reacted with A4 cell lysate, producing a threefold to fourfold increase in staining intensity over that of 3T3 cells not reacted with lysate (data not shown). Others have found that Mac-l mediates the adhesion of neutrophils to fetal-lung fibroblasts. This adhesion did not involve fibronectin or type IV collagen, it was marginally inhibited by RGDS and GRGDS peptides, and adhesion was modulated by polyanions."8 CD45 may function in both adhesion and signaling, with signal transduction occurring via the tyrosine phosphatase activity of the cytoplasmic domain. Experiments using mutant CD45-cells lines showed that CD45 is essential for antigen-induced proliferative responses of T lymphocyte~.~~ The engagement of CD45 with its ligand probably provides a signal for proliferation presumably by dephosphorylation of tyrosine residues on one or more substrates. Experiments with its B-lymphocyte ligand, CD22, support this interpretati~n.~"~' In A4 cells and in the myeloid system generally, CD45 may act in association with cytokines to regulate proliferation. A study with human myeloid progenitor cells, in which antibodies and antisense oligonucleotides were used to decrease cell-surface CD45 expression, indicated that CD45 is required for proliferation of progenitor cells stimulated by IL-3 and GM-CSF. 52 It is believed that hematopoiesis is regulated through signals from cytokines and stromal cells. The model system of A4 cells in coculture with 3T3 cells has provided clues to molecules involved in the interaction of myeloid progenitors with stromal fibroblasts. A molecule central to this interaction appears to be stromal cell heparan sulfate. It is a ligand for cell-surface molecules involved in adhesion and signaling and it probably also acts to immobilize cytokines within the stromal layer." Cell-surface heparan sulfate proteoglycans usually extend well into the glycocalyx and hence are ideal initial tethering ligands for cell-adhesion molecules. It is envisaged that CD45 and Mac-l bind initially to heparan sulfate, tethering the progenitor cells to the stromal layer. This tethering by heparan sulfate would bring the progenitors into direct contact with stromal cytokines. Cytokine stimulaFor personal use only. on April 13, 2017 . by guest www.bloodjournal.org From tion of the A4 cells may induce adhesion via a heparan sulfate independent mechanism in a manner analogous to the induction of T-lymphocyte adhesion to VCA"1 by a cytokine immobilized on a heparan sulfate pr~teoglycan.~~ Whether the molecular interactions described in this report apply to the maintenance of homeostasis within the BM awaits investigation.
